Posted by Michael Wonder on 16 Feb 2022
Rapid Medical receives FDA breakthrough device designation for vasospasm treatment
15 February 2022 - Comaneci temporarily expands blood vessels, recognised as novel device for life-threatening disease.
Rapid Medical today announced FDA breakthrough designation for its Comaneci embolisation assist device to facilitate the treatment of cerebral vasospasm following hemorrhagic stroke.
Read Rapid Medical press release
